Author

Emily Largent

  • Advanced Care & Aging

    Aducanumab: A Bitter Pill to Swallow

    Patients are understandably desperate, but their needs are best served by following the science, rather than lowering the standards for drugs.

    Aducanumab: A Bitter Pill to Swallow

    Hundred dollar bills rolled up in a pill bottle
  • Health Law Policy

    Should we Pay Organ Donors? A Response to the Washington Post

    A real-world test of regulated payments is needed to show definitively whether this is a viable method of increasing the supply of kidneys for transplantation or not.

    Should we Pay Organ Donors? A Response to the Washington Post

    A group of surgeons perform an operation in a hospital operating theatre.
  • Disability

    State-Level Solutions to Discrimination in Organ Transplants 

    By Emily Largent In recent years, alleged instances of discrimination against people with disabilities in organ transplantation have captured public attention. In 2012, for example, the parents of Amelia Rivera, a child with Wolf-Hirschhorn syndrome, alleged that they were told their daughter was not a candidate for a kidney transplant…

    State-Level Solutions to Discrimination in Organ Transplants 

  • Health Law Policy

    Remembering Alan Wertheimer

    By Emily Largent A week ago, I received the sad news that Alan Wertheimer had passed away. Alan made many important contributions to the philosophical literature, including Coercion and Exploitation. And while Alan would tell you…

    Remembering Alan Wertheimer

  • Empirical

    Pay Disparities in Nursing

    By Emily Largent I’ve mentioned on this blog before that I had a past life as a nurse.  Therefore, I wanted to call attention to an important new study that has just come out in JAMA:…

    Pay Disparities in Nursing

  • Pediatrics

    M.C. v. Aaronson – Update

    By Emily Largent In 2013, M.C. (a minor child), by and through his adoptive parents, filed a complaint in federal district court against the physicians who recommended and performed M.C.’s sex assignment surgery and the South…

    M.C. v. Aaronson – Update

  • FDA

    UCLA, CREA, and FDA

    By Emily Largent Before law school, I worked as a nurse at Ronald Reagan UCLA Medical Center.  The work was interesting, as was the news.  I was there when the Los Angeles Times published an investigation…

    UCLA, CREA, and FDA

  • Health Law Policy

    Vaccines and the Presidential Campaign

    By Emily Largent The 2016 Presidential race is gathering steam, and this has led me to wonder what–if any–effect the recent measles outbreak might have on campaigns.  While a majority of the public holds the view that…

    Vaccines and the Presidential Campaign

  • Health Law Policy

    2014: A Great Year for Orphan Drugs

    By Emily Largent In America, an orphan disease or condition is defined by law as one that affects fewer than 200,000 people.  Six to seven-thousand different rare diseases have been identified, and new rare diseases are regularly described in…

    2014: A Great Year for Orphan Drugs